HCRTR2 rs1408846: What Your Genotype Means
The rs1408846 variant is a genetic change in the HCRTR2 gene that results in a Val308Ile amino acid substitution. It has been associated with variations in daytime sleepiness, napping frequency, and sleep architecture.
What each genotype means
Typical daytime alertness
You carry two copies of the common G allele, encoding the standard valine at position 308 of the hypocretin/orexin receptor 2. Individuals with this baseline genotype typically show standard daytime wakefulness patterns and average sleep architecture in population studies. Because evidence linking this locus to daytime somnolence is limited, your genotype is considered representative of the general population baseline.
Carried by approximately 60% to 70% of people of European descent and more than 80% of individuals of East Asian ancestry.
Slightly altered sleep propensity
You carry one copy of the A allele, which results in an isoleucine substitution at position 308 of the orexin receptor 2. Some preliminary research associates this variant with subtle shifts in daytime somnolence and altered sleep architecture, though overall evidence remains limited and findings are not conclusive. Having this single variant allele represents a modest statistical tendency rather than a clinical sleep disorder.
Present in roughly 25% to 35% of individuals of European ancestry and approximately 15% of East Asian populations.
Potential altered sleep architecture
You carry two copies of the less common A allele, resulting in homozygous isoleucine at codon 308 of the hypocretin receptor 2. In exploratory studies, this genotype has been evaluated for associations with daytime sleepiness and variations in sleep continuity, but published findings remain limited and mixed across cohorts. This genotype does not diagnose hypersomnia or narcolepsy, and everyday lifestyle factors remain primary determinants of sleep quality.
Found in about 2% to 5% of individuals of European ancestry and under 1% of East Asian individuals.
Understanding the rs1408846 Variant
The rs1408846 variant is a single nucleotide polymorphism (SNP) located within the HCRTR2 gene, which encodes the hypocretin receptor 2. This specific variant is classified as a non-synonymous change, meaning it alters the genetic code in a way that results in a different amino acid being incorporated into the protein structure. Specifically, it causes a substitution of valine for isoleucine at position 308 (Val308Ile). Because this change occurs in a receptor protein that is critical for signaling, researchers have investigated whether this structural modification influences how the receptor functions within the brain. While the variant is well-documented in genetic databases, it is important to note that the presence of this SNP is only one of many factors that contribute to an individual's complex sleep profile.
The Role of the HCRTR2 Gene
The HCRTR2 gene provides instructions for making the hypocretin receptor 2, also known as the orexin receptor 2. This receptor is a G protein-coupled receptor that binds to neuropeptides called orexins (or hypocretins). These neuropeptides are essential for regulating the sleep-wake cycle, energy balance, and arousal. By binding to its receptors, orexin helps maintain wakefulness and prevents the sudden transitions into sleep that characterize certain sleep disorders. Because HCRTR2 is a key component of the brain's arousal system, it has long been a subject of interest in sleep research. Understanding how variations in this gene might affect receptor sensitivity or signaling pathways is a major focus for scientists studying why sleep patterns differ so significantly between individuals.
Research and Sleep Associations
Scientific research has explored the link between the rs1408846 variant and various sleep-related traits. Some studies have suggested that this variant is associated with increased daytime sleepiness, higher napping frequency, and differences in sleep timing, such as morningness chronotype. However, the evidence strength for these associations is currently considered limited. While some genome-wide association studies have identified signals in the region of the HCRTR2 gene, the functional impact of the Val308Ile substitution remains a topic of ongoing investigation. It is crucial to understand that genetic associations are statistical in nature and do not imply a direct cause-and-effect relationship for any single person. Many environmental, lifestyle, and other genetic factors also play significant roles in determining how an individual experiences sleep.
Population Frequency
The frequency of the rs1408846 variant varies across different ancestral populations. Data indicates that the minor allele frequency is approximately 0.15 to 0.22 in European populations, while it is observed at a lower frequency of approximately 0.08 in East Asian populations. These differences highlight the importance of considering ancestry when interpreting genetic data. Because the variant is relatively common in some groups, it is considered a normal part of human genetic diversity rather than a rare mutation. Researchers often use these frequency differences to help refine their understanding of how specific variants might have evolved or how they interact with other genetic markers within different populations.
Interpreting Your Genetic Information
If you have access to your genetic data regarding the rs1408846 variant, it is important to view this information as a small piece of a much larger puzzle. Genetic testing for this variant is not a diagnostic tool for sleep disorders, and it cannot predict your specific sleep quality or habits. Because the evidence linking this SNP to sleep traits is limited and the effects are likely very small, this information should not be used to make medical decisions. If you are concerned about your sleep patterns, daytime fatigue, or other sleep-related issues, the most effective approach is to consult with a healthcare professional or a sleep specialist. They can provide a comprehensive evaluation that considers your overall health, lifestyle, and clinical symptoms, which are far more informative than any single genetic variant.
How common is this variant?
The minor allele frequency is approximately 0.15-0.22 in Europeans and 0.08 in East Asians.
Frequently asked questions
Does the rs1408846 variant cause narcolepsy?
No, the rs1408846 variant is not a known cause of narcolepsy. While the HCRTR2 gene is involved in the orexin system, which is linked to narcolepsy, this specific SNP is a common variant associated with minor variations in sleep traits, not the clinical diagnosis of a sleep disorder.
Can I use this SNP to predict if I am a morning person?
Genetic variants like rs1408846 have been statistically associated with chronotype, but they have very low predictive power. Your sleep timing is influenced by a vast number of genes and environmental factors, making it impossible to predict your sleep preferences based on this single variant.
Should I change my sleep habits based on my HCRTR2 genotype?
No, you should not change your sleep habits based on this genotype. Genetic associations are for research purposes and do not provide actionable medical advice. Always prioritize healthy sleep hygiene practices and consult a doctor if you have concerns about your sleep.
Is the Val308Ile change dangerous?
The Val308Ile change is a common genetic variation found in the general population. It is not considered a dangerous mutation, but rather a normal variation in the HCRTR2 protein that may subtly influence how the receptor functions.
Sources & further reading
Educational information only, last refreshed 10/12/2026. Not medical advice — these associations describe population statistics, not individual predictions.
Curious what your genotype is for rs1408846?
Upload a raw DNA file from 23andMe, AncestryDNA, MyHeritage, or FamilyTreeDNA and see this variant — plus thousands more — interpreted in your full report.
Get my report — $29Related variants in HCRTR2
While historically investigated for cluster headache susceptibility, recent large-scale meta-analyses and genetic association studies have yielded inconsistent or non-significant results regarding its clinical impact.
Hypocretin/orexin receptor 2 regulatory variant linked to excessive daytime sleepiness and disrupted REM sleep stabilization.
Variant in HCRTR2 associated with sleep architecture and daytime sleepiness.